S

Signos

HealthUnited States· B2C

Signos is a health technology company that focuses on using continuous glucose monitoring (CGM) technology to help individuals manage their weight. The company aims to expand the application of CGM beyond diabetes, targeting consumers interested in weight loss solutions. This funding round will support their efforts to broaden the use of CGM technology in the weight management market.

$20MVisit website ↗

🏆 Featured in Datapile’s Q2 2026 USA Funding Report

Read the Q2 2026 USA report →
Add this badge to your site
Featured in Datapile’s Q2 2026 USA Funding Report
<a href="https://datapile.co/reports/q2-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 USA Funding Report</a>

Funding history

  1. $20M2026-05-31
    Source: news.google.com ↗

More Health companies

Recently funded startups in the same category.

Related on Datapile